[Federal Register Volume 83, Number 176 (Tuesday, September 11, 2018)]
[Notices]
[Page 45948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-19607]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: October 10, 2018.
    Time: 10:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Chelsea D. Boyd, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers 
Lane, MSC-9823, Rockville, MD 20852-9834, 240-669-2081, 
<a href="/cdn-cgi/l/email-protection#b8dbd0ddd4cbddd996dad7c1dcf8d6d1d096dfd7ce"><span class="__cf_email__" data-cfemail="0b68636e67786e6a256964726f4b656263256c647d">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
Cooperative Agreement (U01 Clinical Trial Required) and NIAID SBIR 
Phase II Clinical Trial Implementation Cooperative Agreement (U44 
Clinical Trial Required).
    Date: October 10, 2018.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, Ph.D., Scientific Review 
Officer, NIAID/NIH/DHHS, Scientific Review Program,5601 Fishers 
Lane, Room 3G13, Rockville, MD 20852, 240-669-5047, 
<a href="/cdn-cgi/l/email-protection#aeccc9dbdddacfc8ddc1c0eec0c7cfc7ca80c0c7c680c9c1d8"><span class="__cf_email__" data-cfemail="dbb9bcaea8afbabda8b4b59bb5b2bab2bff5b5b2b3f5bcb4ad">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-19607 Filed 9-10-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>